Literature DB >> 17669782

Using non-steroidal anti-inflammatory drugs (NSAIDs) following pleurodesis.

Ian Hunt1, Elaine Teh, Rachel Southon, Tom Treasure.   

Abstract

A best evidence topic in cardiothoracic surgery was written according to a structured protocol. The question addressed was whether non-steroidal anti-inflammatory drugs (NSAIDs) decrease the effect of pleurodesis. Only 17 papers were identified using the search below. Three papers presented the best evidence to answer the clinical question. The author, journal, date and country of publication, patient group studied, study type, relevant outcomes, results, and study weaknesses of the papers are tabulated. We conclude that despite a limited number and type of study, there is some histopathological evidence to support the concern that NSAIDs may reduce effectiveness of pleurodesis. Until further clinical studies with appropriate outcome measures are available, NSAIDs following pleurodesis should be used with caution and probably avoided routinely.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17669782     DOI: 10.1510/icvts.2006.140400

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  8 in total

1.  Nonsteroidal antiinflammatory medications: efficient and safe treatment following video-assisted pleurodesis for spontaneous pneumothorax.

Authors:  Alon Ben-Nun; Nir Golan; Irena Faibishenko; David Simansky; Michalle Soudack
Journal:  World J Surg       Date:  2011-11       Impact factor: 3.352

Review 2.  Treating Recurrent Pleural Disease: A Review of Indications and Technique for Chemical Pleurodesis for the Interventional Radiologist.

Authors:  Surbhi B Trivedi; Matthew Niemeyer
Journal:  Semin Intervent Radiol       Date:  2022-08-31       Impact factor: 1.780

3.  Video-assisted thoracoscopic surgery (VATS) for bilateral primary spontaneous pneumothorax.

Authors:  Yi-jen Chen; Shi-ping Luh; Kun-yen Hsu; Cheng-ren Chen; Thomas Chang-yao Tsao; Jia-yuh Chen
Journal:  J Zhejiang Univ Sci B       Date:  2008-04       Impact factor: 3.066

4.  Do concomitant ascites influence the effectiveness of palliative surgical management of pleural effusion in patients with malignancies?

Authors:  Jefferson Luiz Gross; Tatiana Guilherme Disanzio; Riad Naim Younes; Fabio José Haddad; Rodrigo Afonso da Silva; Antonio Bomfim Marçal Avertano
Journal:  World J Surg       Date:  2009-02       Impact factor: 3.352

Review 5.  Interventional pulmonologist perspective: treatment of malignant pleural effusion.

Authors:  Andrew J Sweatt; Arthur Sung
Journal:  Curr Treat Options Oncol       Date:  2014-12

6.  Non-steroid anti-inflammatory drugs reduce the efficacy of autologous blood pleurodesis.

Authors:  Serhat Yalçınkaya; Ulviye Yalçınkaya
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2019-06-05       Impact factor: 0.332

7.  Risk Factors for Chest Pain and Fever in Patients Undergoing Pleurodesis with OK-432.

Authors:  Yoshihito Morimoto; Hidefumi Takei; Keisei Tachibana; Yoko Nakazato; Ryota Tanaka; Yasushi Nagashima; Kazuhiro Watanabe; Reisuke Seki; Takao Shinohara; Haruhiko Kondo
Journal:  Intern Med       Date:  2018-02-09       Impact factor: 1.271

8.  Recurrence of spontaneous pneumothorax six years after VATS pleurectomy: evidence for formation of neopleura.

Authors:  Peter Germonpre; Elke Van Renterghem; Nicolas Dechamps; Thierry Onghena; Joke Van Aken
Journal:  J Cardiothorac Surg       Date:  2020-07-28       Impact factor: 1.637

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.